 | • レポートコード：TPM-B05037 • 出版社/出版日：Transparency Market Research / 2018年4月24日 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール • 産業分類：Healthcare |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、子宮頚部異形成の世界市場について調べ、子宮頚部異形成の世界規模、市場動向、市場環境、診断別（検査、装置）分析、エンドユーザー別（病院、診断センター、民間婦人科診療所、研究・学術機関、通院外科診療所）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・子宮頚部異形成の世界市場動向 ・子宮頚部異形成の世界市場環境 ・子宮頚部異形成の世界市場規模 ・子宮頚部異形成の世界市場規模：診断別（検査、装置） ・子宮頚部異形成の世界市場規模：エンドユーザー別（病院、診断センター、民間婦人科診療所、研究・学術機関、通院外科診療所） ・子宮頚部異形成の世界市場：地域別市場規模・分析 ・子宮頚部異形成の北米市場規模・予測 ・子宮頚部異形成のアメリカ市場規模・予測 ・子宮頚部異形成の中南米市場規模・予測 ・子宮頚部異形成のヨーロッパ市場規模・予測 ・子宮頚部異形成のアジア市場規模・予測 ・子宮頚部異形成の中東市場規模・予測 ・子宮頚部異形成のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Cervical Dysplasia Market: Scope and Methodology
This report on the global cervical dysplasia market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global cervical dysplasia market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global cervical cancer market.
Market revenue in terms of US$ Mn for the period between 2017 and 2024 along with the compound annual growth rate (CAGR %) from 2017 to 2024 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of cancer and other chronic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Cervical Dysplasia Market: Segmentation
Based on the diagnosis, the market has been further segmented into two major segments namely, diagnosis tests and diagnostic devices. Diagnosis segment further sub-segmented into Pap smear test, HPV test, and Biopsy. Moreover, colposcope devices are considered as diagnostic devices for cervical dysplasia market in this report. Based on end user, the market has been segmented into hospitals, diagnostic centers, private gynecological offices, research & academic institutes and ambulatory surgical centers.
Cervical Dysplasia Market: Geographical and Competitive Dynamics
Geographically, the global cervical dysplasia market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Saudi Arabia, UAE, Brazil, and Mexico.
The report also profiles major players in the cervical dysplasia market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include F. Hoffmann La-Roche Ltd., QIAGEN, Becton, Dickinson and company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., and Abbott Healthcare Pvt Ltd, exhibit the largest geographical outreach with presence in cervical dysplasia product categories.
The global cervical dysplasia market is segmented as follows:
Global Cervical Dysplasia Market Revenue, by Diagnosis
Diagnosis Test
Pap Smear Test
HPV Test
Biopsy
Diagnostic Device
Colposcopy
Global Cervical Dysplasia Market Revenue, by End User
Hospitals
Diagnostic Centers
Private Gynecologists’ Offices
Research & Academic Institutes
Ambulatory Surgical Centers
Global Cervical Dysplasia Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
Rest of Middle East & Africa
Section – 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section – 2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology
Section-3 Executive Summary
3.1 Global Cervical Dysplasia: Market Snapshot
3.2 Global Cervical Dysplasia Market: Opportunity Map
Section-4 Market Overview
4.1 Global Cervical Dysplasia Market: Key Industry Developments
Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.1.2 Drivers
5.1.2.1 Increasing cervical screening programs
5.1.2.2 Rising Prevalence of Cervical Cancer in aging population
5.1.2.3 Government Funding On Cancer Screening Programs
5.1.2.4 Favorable Government policies
5.1.2.5 Awareness campaigns
5.1.2.6 Increasing Cigarette Smokers around the Globe
5.1.2.7 Government organization recommendations
5.1.3 Restraints
5.1.3.1 Low awareness in underdeveloped countries hinders the growth of the market
5.1.3.2 HPV vaccination recommendations
5.1.3.3 Changes in Government Policies
5.2 Global Cervical Dysplasia Market Revenue Projection
5.3 Porter’s Five Forces Analysis
5.4 Cervical Dysplasia Market Outlook
Section-6 Cervical Dysplasia Market Analysis, By Diagnosis
6.1 Key Findings
6.2 Introduction
6.3 Global Cervical Dysplasia Market Value Share Analysis, By Diagnosis Type
6.4 Global Cervical Dysplasia Market Forecast, By Diagnosis Type
6.4.1 Diagnostic Test
6.4.1.1. HPV Test
6.4.1.2. Pap Smear Test
6.4.1.3. Biopsy
6.4.2 Diagnostic Devcie
6.4.2.1. Colposcopy
6.5 Global Cervical Dysplasia Market Attractiveness Analysis, By Diagnosis Type
Section-7 Global Cervical Dysplasia Market Analysis, By End User
7.1 Key Findings
7.2 Introduction
7.3 Global Cervical Dysplasia Market Value Share Analysis, By End User
7.4 Global Cervical Dysplasia Market Forecast, By End User
7.4.1 Hospitals
7.4.2 Diagnostic Centers
7.4.3 Ambulatory Surgical Centers
7.4.4 Private Gynecologist’s Offices
7.4.5 Research & Academic institutes
7.5 Global Cervical Dysplasia Market Attractiveness Analysis, By End User
Section-8 North America Cervical Dysplasia Market Analysis
8.1 Key Findings
8.2 North America Cervical Dysplasia Market Overview
8.3 North America Market Value Share Analysis, By Diagnosis Type
8.3.1 North America Market Forecast, By Diagnosis Type
8.4 North America Market Value Share Analysis, By End User
8.4.1 North America Market Forecast, By End User
8.5 North America Market Forecast, By Country
8.6 North America Market Attractiveness Analysis
8.7 North America Market Trends
Section-9 Europe Cervical Dysplasia Market Analysis
9.1 Key Findings
9.2 Europe Cervical Dysplasia Market Overview
9.3 Europe Market Value Share Analysis, By Diagnosis Type
9.3.1 Europe Market Forecast, By Diagnosis Type
9.4 Europe Market Value Share Analysis, By End User
9.4.1 Europe Market Forecast, By End User
9.5 Europe Market Forecast, By Country
9.6 Europe Market Attractiveness Analysis
9.7 Europe Market Trends
Section-10 Asia Pacific Cervical Dysplasia Market Analysis
10.1 Key Findings
10.2 Asia Pacific Cervical Dysplasia Market Overview
10.3 Asia Pacific Market Value Share Analysis, By Diagnosis Type
10.3.1 Asia Pacific Market Forecast, By Diagnosis Type
10.4 Asia Pacific Market Value Share Analysis, By End User
10.4.1 Asia Pacific Market Forecast, By End User
10.5 Asia Pacific Market Forecast, By Country
10.6 Asia Pacific Market Attractiveness Analysis
10.7 Asia Pacific Market Trends
Section-11 Latin America Cervical Dysplasia Market Analysis
11.1 Key Findings
11.2 Latin America Cervical Dysplasia Market Overview
11.3 Latin America Market Value Share Analysis, By Diagnosis Type
11.3.1 Latin America Market Forecast, By Diagnosis Type
11.4 Latin America Market Value Share Analysis, By End User
11.4.1 Latin America Market Forecast, By End User
11.5 Latin America Market Forecast, By Country
11.6 Latin America Market Attractiveness Analysis
11.7 Latin America Market Trends
Section-12 Middle East and Africa Cervical Dysplasia Market Analysis
12.1 Key Findings
12.2 Middle East and Africa Market Overview
12.3 Middle East and Africa Market Value Share Analysis, By Diagnosis Type
12.3.1 Middle East and Africa Market Forecast, By Diagnosis Type
12.4 Middle East and Africa Market Value Share Analysis, By End User
12.4.1 Middle East and Africa Market Forecast, By End User
12.5 Middle East and Africa Market Forecast, By Country
12.6 Middle East and Africa Market Attractiveness Analysis
Section-13 Competition Landscape
13.1. Competition Matrix
13.2. Company Profiles
13.2.1. Becton, Dickinson and company.
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Financial Overview
13.2.1.3. Diagnosis Portfolio
13.2.1.4. SWOT Analysis
13.2.1.5. Strategic Overview
13.2.2 Hologic, Inc
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Financial Overview
13.2.2.3. Diagnosis Portfolio
13.2.2.4. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3 Micromedic Technologies Ltd.
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Financial Overview
13.2.3.3. Diagnosis Portfolio
13.2.3.4. SWOT Analysis
13.2.3.5. Strategic Overview
13.2.4 OncoHealth Corporation
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Financial Overview
13.2.4.3. Diagnosis Portfolio
13.2.4.4. SWOT Analysis
13.2.4.5. Strategic Overview
13.2.5 Quest Diagnostics, Inc
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Financial Overview
13.2.5.3. Diagnosis Portfolio
13.2.5.4. SWOT Analysis
13.2.5.5. Strategic Overview
13.2.6 F. Hoffmann La-Roche Ltd.
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Financial Overview
13.2.6.3. Diagnosis Portfolio
13.2.6.4. SWOT Analysis
13.2.6.5. Strategic Overview
13.2.7 QIAGEN N.V.
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Financial Overview
13.2.7.3. Diagnosis Portfolio
13.2.7.4. SWOT Analysis
13.2.7.5. Strategic Overview
13.2.8 Abbott Laboratories
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Financial Overview
13.2.8.3. Diagnosis Portfolio
13.2.8.4. SWOT Analysis
13.2.8.5. Strategic Overview
Table 01: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 02: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 03: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, by Region, 2015–2024
Table 04: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by Diagnosis Type, 2015–2024
Table 05: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by End-user, 2015–2024
Table 06: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by Country, 2015–2024
Table 07: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 08: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 09: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 10: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 11: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 12: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 13: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 14: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 15: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 15: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 16: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024